FDA Webview
X

Free FDA Notices

FDA OKs Pfizer’s NADA for Parasite Treatment

08/10/2004
Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a supplemental NADA filed by Pfizer, Inc. that provides for an increased period of protection from reinfection with three species of internal parasites following topical administration of doramectin solution on cattle. To view this final rule, click here.

LATEST NEWS